These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Spontaneous resolution of transient abnormal myelopoiesis between 34 and 40 weeks gestation. Maracaja DLV, Rinder H. Br J Haematol; 2020 Feb; 188(4):481. PubMed ID: 31815289 [No Abstract] [Full Text] [Related]
8. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome. Watanabe K. Pediatr Int; 2019 Mar; 61(3):222-229. PubMed ID: 30593694 [Abstract] [Full Text] [Related]
9. Enigma of myeloid proliferation in Down syndrome. Hasegawa D. Pediatr Int; 2019 Mar; 61(3):221. PubMed ID: 30916856 [No Abstract] [Full Text] [Related]
10. Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update. Bhatnagar N, Nizery L, Tunstall O, Vyas P, Roberts I. Curr Hematol Malig Rep; 2016 Oct; 11(5):333-41. PubMed ID: 27510823 [Abstract] [Full Text] [Related]
12. The hematopoietic microenvironment of the fetal liver and transient abnormal myelopoiesis associated with Down syndrome: A review. Miyauchi J. Crit Rev Oncol Hematol; 2024 Jul; 199():104382. PubMed ID: 38723838 [Abstract] [Full Text] [Related]
13. Complete blood count differences in a cohort of Down syndrome neonates with transient abnormal myelopoiesis screened for GATA1 pathogenic variants. Orozco-Vela M, Corona-Rivera A, Cruz-Osorio RM, Mendoza-Maldonado L, Márquez-Mora A, Barba-Barba CC, Peña-Padilla C, Baldomero-López A, Bobadilla-Morales L, Corona-Rivera JR. Am J Med Genet A; 2020 Sep; 182(9):2085-2093. PubMed ID: 32681702 [Abstract] [Full Text] [Related]
15. Transient abnormal myelopoiesis in a cytogenetically normal neonate. Yanase K, Kato K, Katayama N, Mouri Y, Kobayashi C, Shiono J, Abe M, Yoshimi A, Koike K, Arai J, Tsuchida M. Int J Hematol; 2010 Oct; 92(3):527-30. PubMed ID: 20859711 [Abstract] [Full Text] [Related]
16. Transient abnormal myelopoiesis of a newborn not associated with chromosome 21 abnormalities or GATA1 mutations. Nakashima MO, Shetty S, Chicka M, Flagg A, Eng C, Cotta CV. Pediatr Blood Cancer; 2015 Feb; 62(2):353-355. PubMed ID: 25175265 [Abstract] [Full Text] [Related]
17. Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with GATA1 mutation. Nishinaka-Arai Y, Niwa A, Matsuo S, Kazuki Y, Yakura Y, Hiroma T, Toki T, Sakuma T, Yamamoto T, Ito E, Oshimura M, Nakahata T, Saito MK. Haematologica; 2021 Feb 01; 106(2):635-640. PubMed ID: 32354872 [No Abstract] [Full Text] [Related]
18. Liver fibrosis with hypereosinophilia causing transient abnormal myelopoiesis. Minakata S, Sakata N, Wada N, Konishi Y, Marutani S, Enya T, Nakagawa H, Wada H, Takemura T. Pediatr Int; 2016 Nov 01; 58(11):1222-1225. PubMed ID: 27709778 [Abstract] [Full Text] [Related]
19. Twin-to-twin transmission of transient abnormal myelopoiesis without constitutional trisomy 21: A case report. Roseman AS, Blackburn PR, Bakshi S, Grady L, Abbott MA, Hassan S, Hunt J, Richardson M, Peterson JF, Nguyen P, Greipp PT, Singh R. Cancer Genet; 2020 Jun 01; 244():62-64. PubMed ID: 32464589 [No Abstract] [Full Text] [Related]
20. GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder. Lum SH, Choong SS, Krishnan S, Mohamed Z, Ariffin H. Singapore Med J; 2016 Jun 01; 57(6):320-4. PubMed ID: 27353457 [Abstract] [Full Text] [Related] Page: [Next] [New Search]